Doximity, a digital platform for medical professionals, is subject to a class action lawsuit alleging it made false or misleading statements about its revenue growth and market position. The lawsuit claims Doximity overstated the impact of its Newsfeed on revenue and lost market share to competitors with better pricing and engagement strategies. Stock price drops followed announcements of cautious ad spending outlooks, lowered revenue guidance, and missed revenue targets between 2025 and 2026. Investors who bought Doximity stock between August 2024 and May 2026 can seek lead plaintiff status in the case by November 16, 2026.
The Doximity class action lawsuit is the subject of this update, provided here with Pluang's Health sector market data as of Sep 18, 2026 03:42 WIB. Among 91 priced Health-sector US stocks on Pluang, 60 advanced while 30 declined. Notably, Illumina, Inc. (ILMN) and Enveric Biosciences Inc (ENVB) both rose by 6.71%, with ILMN seeing 100% buy orders and a typical hold time of 86 days, contrasting with ENVB's shorter 12-day hold time and 60% buy orders. Sana Biotechnology Inc (SANA) also gained 6.34%, supported by 71% buy orders and a 22-day typical hold time.
Jefferies maintained a Hold rating on Kinder Morgan, lowering its price target from $35 to $33, which remains above the current stock price of $31.31. The company benefits from stable cash flows, with 96% secured by fee-based or hedged contracts, inc...
Several stocks saw sharp gains driven by key company developments. bioAffinity Technologies surged 63.55% after securing a Hong Kong patent for its lung cancer diagnostic technology, boosting its Asian market position. Antelope Enterprise Holdings ro...
Global Compliance Applications Corp. has appointed Peter Wises as Managing Director - Asia and Co-Chairman to lead its business development and institutional partnerships in the Asia-Pacific region. Wises will focus on expanding the company's blockch...
Cash Cat (CASHCAT) led the top 200 cryptocurrencies by market cap with a 32% daily gain, driven by a new DeFi utility on Morpho’s platform and renewed memecoin interest. Its trading volume jumped over 65%, surpassing $40 million, while the price brok...
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
